The english version of the website of the School of Medicine is under development

Δημοσίευση

Evidence-based (S3) guideline for the treatment of androgenetic alopecia in women and in men - short version.

TitleEvidence-based (S3) guideline for the treatment of androgenetic alopecia in women and in men - short version.
Publication TypeJournal Article
Year of Publication2018
AuthorsKanti, V., Messenger A., Dobos G., Reygagne P., Finner A., Blumeyer A., Trakatelli M., Tosti A., del Marmol V., Piraccini B. M., Nast A., & Blume-Peytavi U.
JournalJ Eur Acad Dermatol Venereol
Volume32
Issue1
Pagination11-22
Date Published2018 Jan
ISSN1468-3083
Keywords5-alpha Reductase Inhibitors, Alopecia, Drug Therapy, Combination, Dutasteride, Evidence-Based Medicine, Female, Finasteride, Hair, Humans, Low-Level Light Therapy, Male, Minoxidil, Outcome Assessment (Health Care), Platelet-Rich Plasma, Practice Guidelines as Topic, Vasodilator Agents
Abstract

Androgenetic alopecia is the most common hair loss disorder, affecting both men and women. Initial signs of androgenetic alopecia usually develop during teenage years leading to progressive hair loss with a pattern distribution. Moreover, its frequency increases with age and affects up to 80% Caucasian men and 42% of women. Patients afflicted with androgenetic alopecia may undergo significant impairment of quality of life. The European Dermatology Forum (EDF) initiated a project to develop evidence-based guidelines for the treatment of androgenetic alopecia. Based on a systematic literature research the efficacy of the currently available therapeutic options was assessed and therapeutic recommendations were passed in a consensus conference. The purpose of the guideline is to provide dermatologists with an evidence-based tool for choosing an efficacious and safe therapy for patients with androgenetic alopecia.

DOI10.1111/jdv.14624
Alternate JournalJ Eur Acad Dermatol Venereol
PubMed ID29178529

Contact

Secretariat of the School of Medicine
 

Connect

Schoole of Medicince presence in social networks
Follow Us or Connect with us.